does semaglutide help with sleep apnea Apnea? Weight Loss & Better Rest What if the future of

The rapid rise of GLP-1 receptor agonists like semaglutide and tirzepatide has transformed obesity and diabetes care, generating billions in revenue for manufacturers Novo Nordisk and Eli Lilly, while creating unprecedented demand for weight management solutions

However, awareness of this potential adverse effect allows for proactive management and appropriate patient counselling before and during treatment

These findings argue against a hepatic portal site of action of GLP-1 to inhibit eating, and further emphasize that the route of administration is an important consideration when analyzing food intake inhibition by GLP-1R agonism

Renal and hepatic function are important considerations, as impaired organ function can affect drug metabolism and clearance

Supply chain issues pose the potential for accessibility limitations